Not catalog-first. Target-first.
Four binder chassis, chosen strictly on the merits of your binding interface.
Fab / scFv designs with established manufacturing and regulatory precedent.
Single-domain VHH framework with camelid-derived loop flexibility.
De novo scaffolds offering high stability and precise interface targeting.
Constrained macrocycles with cell permeability and oral bioavailability potential.